Jennifes replyItis our understanding that studies are indeed underway in the U.S.involving the Epitopix vaccine. I cannot comment on the results.
The "protecting your brand" marketing strategy being used with Econiche in Canadahas some traction, however, Canada has much less "branded product" thanthe U.S. Over half of the beef products sold in the U.S. are brandedproducts and we have seen significant interest from within specificbrands in the U.S. to implement vaccination as a risk reductionstrategy. This interest has increased given the rejection by the USDA ofa petition filed in support of whole carcass irradiation, a technologybeing pursued by Cargill and other companies to reduce risk.
Jennifer
/us.mc1612.mail.yahoo.com/mc/compose?to=Jennifer.Shea@Bioniche.com" target="_blank" rel="nofollow">Jennifer.Shea@Bioniche.com
www.Bioniche.com